CHAI has published a white paper examining the opportunities and challenges for new manufacturers aiming to build globally competitive and commercially viable businesses in the low- and middle-income country vaccine markets.
To address these questions, CHAI, BDO, and Kroll conducted extensive interviews with executives from developing country vaccine manufacturers, multi-national companies, and global health ecosystem stakeholders, as well as research into published documents. Through this analysis, we distilled actionable lessons from the history of vaccine markets to provide a roadmap for manufacturers interested in these markets. Coupled with our learnings from ongoing support to partners in the ecosystem, these insights have the potential to propel and increase vaccine adoption and use worldwide.
